Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES - SCHEDULE OF ACCRUED EXPENSES (Details)

v3.24.2.u1
ACCRUED EXPENSES - SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued pre-clinical and clinical costs $ 1,174 $ 1,449
Accrued product development costs 737 745
Accrued license costs 4,125 4,825
Accrued compensation 2,297 2,326
Accrued administrative costs 625 343
Accrued interest 1,530 1,342
Total $ 10,488 $ 11,030